Clinical trial
The Effect of Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin on Coronary Atherosclerotic Plaque by Intravascular Ultrasound (ROSUZET-IVUS Trial)
NCT03169985 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin on Coronary Atherosclerotic Plaque by Intravascular Ultrasound (ROSUZET-IVUS Trial)
- Lead sponsor
- Samsung Medical Center
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- July 12, 2017
- Completion date
- January 28, 2027
- Enrollment
- 280 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.